Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
Abroad (travel likely)Recruiting
Conditions
Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Evidera, a PPD Business Unit /ID# 238688, Morrisville, North Carolina, United States
PPD Development, LP /ID# 232134, Wilmington, North Carolina, United States
Study leads
ABBVIE INC.
Study Director
AbbVie